<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04503954</url>
  </required_header>
  <id_info>
    <org_study_id>TCHIRB-10904004</org_study_id>
    <nct_id>NCT04503954</nct_id>
  </id_info>
  <brief_title>Efficacy of Chronic Disease Self-management Program in People With Schizophrenia</brief_title>
  <official_title>Efficacy of Chronic Disease Self-management Program in People With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taipei University of Nursing and Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taipei University of Nursing and Health Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a randomized controlled behavioral intervention trial to assess the efficacy of&#xD;
      investigating program of chronic disease self-management program in people on schizophrenia&#xD;
      patients conditions of depression, activities of daily living, social function, work, and&#xD;
      quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects were randomized to intervention group and control group. The primary outcome&#xD;
      included eight measures, Stanford Self-Management Questionnaire, the Beck Depression&#xD;
      Inventory-II, the Activities of Daily Living Rating Scale III, the Instrumental Activities of&#xD;
      Daily Living Scale, the Participation Measure-3 Domains, 4 Dimensions, the Work Behavior&#xD;
      Inventory, and the Schizophrenia-Quality of Life questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 7, 2020</start_date>
  <completion_date type="Actual">December 25, 2020</completion_date>
  <primary_completion_date type="Actual">December 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stanford Self-Management Questionnaire</measure>
    <time_frame>6 week</time_frame>
    <description>The Stanford Self-Management Questionnaire is for Chronic Disease Self-management Program. A higher score indicates better self-management. Changes of the Canadian Occupational Performance Measure will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Beck Depression Inventory-II,</measure>
    <time_frame>6 week</time_frame>
    <description>Beck Depression Inventory-II assesses the person about depression. A higher score indicates more depression.&#xD;
Changes of Beck Depression Inventory-II will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activities of Daily Living Rating Scale III,</measure>
    <time_frame>6 week</time_frame>
    <description>Activities of Daily Living Rating Scale III assesses instrumental activities of daily living. A higher score indicates better activities of daily living. Changes of Activities of Daily Living Rating Scale III will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Instrumental Activities of Daily Living</measure>
    <time_frame>6 week</time_frame>
    <description>Instrumental Activities of Daily Living assesses instrumental activities of daily living.&#xD;
A higher score indicates better instrumental activities of daily living. Changes of Instrumental Activities of Daily Living will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participation Measure-3 Domains Domains, 4 Dimensions</measure>
    <time_frame>6 week</time_frame>
    <description>Participation Measure-3 Domains, 4 Dimensions assesses social participation. A higher score indicates better social participation. Changes of Participation Measure-3 Domains, 4 Dimensions will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Work Behavior Inventory</measure>
    <time_frame>6 week</time_frame>
    <description>Work Behavior Inventory assesses work behavior about chronic mental patients. A lower score indicates better work behavior. Changes of Work Behavior Inventory will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schizophrenia-Quality of Life questionnaire</measure>
    <time_frame>6 week</time_frame>
    <description>Schizophrenia-Quality of Life questionnaire assesses schizophrenia quality of life. A higher score indicates better quality of life. Changes of Schizophrenia-Quality of Life questionnaire will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini Mental State Examination-2nd edition</measure>
    <time_frame>6 week</time_frame>
    <description>Mini Mental State Examination general cognitive function. A higher score indicates better general cognitive function.&#xD;
Changes of Mini Mental State Examination will be assessed at the 0 week, 6 weeks.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Self-management group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Self-management group Chronic disease self-management program is conduct training skills, person how to live together with personal chronic disease to make life quality better.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group will continue general psychiatric intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chronic disease self-management program</intervention_name>
    <description>The chronic disease self-management program is based on the self-efficacy theory for improving health behavior, by the solve health problem skill, health life style, emotion management skill, improve intention of health condition in people with chronic disease.</description>
    <arm_group_label>Self-management group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>General psychiatric intervention</intervention_name>
    <description>General psychiatric intervention contains the activities in psychiatric center.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of schizophrenia by DSM-5&#xD;
&#xD;
          -  age &gt; 20 years&#xD;
&#xD;
          -  Stable mental symptoms&#xD;
&#xD;
          -  Willing to sign the subject's consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of severe brain injury&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Diagnosis of intellectual developmental disorder&#xD;
&#xD;
          -  Unable to follow instructions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>En-Chi Chiu, PhD</last_name>
    <role>Study Director</role>
    <affiliation>National Taipei University of Nursing and Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taipei University of Nursing and Health Sciences</name>
      <address>
        <city>Taipei</city>
        <state>Wanhua Dist</state>
        <zip>108306</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>August 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Taipei University of Nursing and Health Sciences</investigator_affiliation>
    <investigator_full_name>En-Chi Chiu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>chronic disease self-management program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

